RELX

RELX

Market cap $62.6B

EXCLUSIVE: Proprietary datasets and massive scale were key differentiators against AI-native competitors—according to finance chief Nick Luff—who said AI was enhancing the company's pricing power.

The IDC MarketScape recognizes the company's strengths in data volume, quality, completeness, coverage and compliance with directory mandates ATLANTA, Feb. 24, 2026 /PRNewswire/ -- LexisNexis® Risk Solutions has once again been named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025-2026 Vendor Assessmenti. The IDC MarketScape study utilizes quantitative and qualitative research to assess the capabilities and business strategies of many of the most prominent provider data management (PDM) vendors for the payer enterprise.

Founded in 1993, but with roots dating back to the late 1800s, RELX is now a $56 billion (by market cap) data and analytics giant that employs more than 35,000 people. RELX has now increased its dividend for 15 consecutive years. Its 10-year dividend growth rate is 7.7%. RELX has a good financial position. The long-term debt/equity ratio is 1.5, while the interest coverage ratio is nearly 10.

Industry-leading identity verification, resolution and enrichment solutions combine with leading AI authentication capabilities to secure, unify and enrich patient identities across the care journey ATLANTA, Feb. 19, 2026 /PRNewswire/ -- LexisNexis® Risk Solutions today announced the launch of an identity management platform with industry leading identity verification, resolution and enrichment solutions that enable healthcare organizations to manage patient and member identities across the entire healthcare journey. Configured specifically for healthcare use cases, the platform enables organizations to confidently verify identities, resolve duplicate records and continuously enhance profiles with social and behavioral insights from beyond their organization.

British information group RELX is preparing to grant its top boss, Erik Engstrom, a substantial pay rise, bringing it closer to its FTSE-100 peers like AstraZeneca , Rolls-Royce and Shell , Sky News reported on Wednesday, citing sources.

ATLANTA, Feb. 18, 2026 /PRNewswire/ -- Shopping for U.S. auto insurance remained in high gear through the fourth quarter of 2025, according to the latest U.S. Insurance Demand Meter from LexisNexis® Risk Solutions. The quarterly year-over-year shopping growth registered "Hot", rising to 6.9% on the Demand Meter, while new policy growth also clenched a "Hot" reading, increasing to 7.1%.

Impax International Sustainable Economy Fund portfolio marginally underperformed MSCI EAFE benchmark, driven primarily by stock-specific effects and style tilts. AstraZeneca's stock has an attractive Sustainability Lens profile with opportunities in Health Care Access & Innovation and Wellbeing. RELX's stock has a high Corporate Resilience score due primarily to environmental and social risk management practices.

RELX PLC (LSE:REL) shares rose 6% after it remained a 'buy' at both Deutsche Bank and UBS following full-year 2025 results, although both banks reduced their price targets to reflect sector de-rating and higher discount rates. Deutsche cut its price target to 3,050p from 3,700p, while UBS moved to 3,600p from 4,570p.

RELX PLC (RELX) Q4 2025 Earnings Call Transcript

The firm remains confident even as the market flips from seeing it as an AI winner to fearing its profit market will implode